05/01/2025
Client Treatment Summary Overview
Current Homecare Regimen:
• Cleanser: Gentle, non-stripping formulation to support barrier integrity
• SPF: Broad-spectrum SPF 30, applied daily for UV protection and barrier preservation
In-Clinic Procedures to Date:
1. Microneedling Session 1
• Depth: 0.5 mm – 1.0 mm, tailored to facial zones
• Actives Needled In:
• PDRN (Polydeoxyribonucleotide): Enhances cellular regeneration and DNA repair
• Hyaluronic Acid: Supports dermal hydration and collagen remodeling
2. Microneedling Session 2 (Completed since initial update)
• Reinforced regenerative and hydrating effects, continuing to stimulate fibroblast activity and skin renewal
Product Integration:
• DMK Acu Mist: Introduced post-treatment to regulate sebaceous activity. Formulated to reduce the cohesiveness of sebum, allowing for better flow and minimizing congestion and inflammatory breakouts.
Planned Final Phase of Active Correction:
• Mandelic Acid Peel: A finishing treatment to enhance skin clarity, refine texture, and target any residual congestion. Mandelic acid is ideal for sensitive or acne-prone skin due to its large molecular size and anti-inflammatory properties.
Maintenance Phase Plan:
• Client will transition into maintenance treatments every 8 weeks, focusing on chemical exfoliation protocols tailored to her skin’s evolving needs. This phase will preserve results, support ongoing cellular turnover, and maintain optimal skin health.
Clinical Observations:
• Increased hydration and moisture retention
• Reduced oil viscosity and surface congestion
• Progressive glow and enhanced skin texture, indicating improved barrier function and dermal health
